Charles River(CRL) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Conduit Pharmaceuticals - Results for Study With Charles River Laboratories Expected in Q2 2025
Reuters08:36 ET
Green Gives Way to Red on Gossamer Macro Expectations: Live Stock News
Kevin TraversMar 18 10:32 ET
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Zhitong FinanceMar 18 03:00 ET
Monday Market Green Like the Irish, But for How Long: Live Stock News
Kevin TraversMar 17 10:55 ET
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Simply Wall StMar 17 10:39 ET
Are Investors Undervaluing Charles River Associates (CRAI) Right Now?
Zacks Mar 17 08:50 ET

Comments

韭菜变主力

Jan 18 12:05

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

韭菜变主力

Dec 30, 2024 15:18

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Moomoo AI

Feb 29, 2024 15:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26, 2024 18:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.

Have Charles River Laboratories International Insiders Been Selling Stock?

Moomoo AI

Feb 16, 2024 23:18

EPS growth outshines the yearly share price gain of 12%, indicating market caution towards the stock. Despite sell-off, long term shareholders gained 12% annually over five years, suggesting the sell-off might be a growth opportunity.

Charles River Laboratories International (NYSE:CRL) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years

1

CRL Charles River

Trade Overview

Capital Trend

News

Comments

Trending Stocks